Lansoprazole sodium
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
Lansoprazole sodium是一种质子泵抑制剂(PPI),同时也可以抑制细胞色素P450[1].
Lansoprazole sodium是取代的苯并咪唑,作为一种抑酸药,已被广泛地用于治疗胃酸分泌相关疾病.Lansoprazole sodium阻断胃壁细胞分泌表面的H+/K+-ATP酶系统,从而抑制胃酸分泌.据报道,人细胞色素P450酶包括CYP2C9\2C19\2D6和3A4,而Lansoprazole sodium竞争性地抑制HLM中的CYP2C9活性,其Ki值为21 μM.在HLM和rCYP2C19测试中,Lansoprazole sodium有效抑制CYP2C19,其Ki值约为1 μM.此外,Lansoprazole sodium抑制CYP2D6以及CYP3A4活性,其IC50值均大于200 μM[1].
参考文献：
[1] Li XQ1, Andersson TB, Ahlstrm M, Weidolf L. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos. 2004 Aug;32(8):821-7.
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 391.34 |
| Cas No. | 226904-00-3 |
| Formula | C16H13F3N3NaO2S |
| Solubility | insoluble in H2O; ≥15.05 mg/mL in EtOH; ≥58.9 mg/mL in DMSO |
| Chemical Name | sodium;2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]benzimidazol-1-ide |
| SDF | Download SDF |
| Canonical SMILES | CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCC(F)(F)F.[Na+] |
| 运输条件 | 蓝冰运输或根据您的需求运输。 |
| 一般建议 | 不同厂家不同批次产品溶解度各有差异，仅做参考。若实验所需浓度过大至产品溶解极限，请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存，请尽快用完。 |
质量控制和MSDS
- 批次:
化学结构
